Baylor Transplant Services

Baylor Transplant


Welcome to Transplant Services

Transplant Services is made up of an elite group of surgeons, headed by Goran B. Klintmalm, M.D., Ph.D., F.A.C.S., Chairman and Chief of Annette C. and Harold C. Simmons Transplant Institute. Established in 1984, Transplant Services works in collaboration with Annette C. and Harold C. Simmons Transplant Institute and is considered one of the leading transplant centers in the nation and one of the largest adult transplant centers in the United States. 

We offer comprehensive treatments for liver, kidney, pancreas, and islet transplantation. With more than 6000 successful solid organs, bone and marrow transplants, we have established a reputation for excellence and innovation in patient care and research. We are proud to participate in more than 60 research protocols and have trained more than 35 transplant surgeons who are now operating worldwide. Our surgeons provide transplant services at two locations, Baylor University Medical Center, Dallas and Baylor All Saints, Fort Worth. 

Living Donor Liver Transplantation at Baylor Transplant Services

Our Living Liver Donor Transplant team is led by Dr. Giuliano Testa. Dr. Testa specializes in living donor liver transplantation for adult patients and is the Surgical Director of Living Donor Liver Transplantation at Baylor University Medical Center. Before joining the Annette C. and Harold C. Simmons Transplant Institute, Dr. Testa was Director of the Living Donor Liver Transplant Program at the University of Illinois and then Director of Liver Transplant and Hepatobiliary Surgery at the University of Chicago.

Dr. Testa has been performing living donor liver transplants for more than a decade. That experience combined with the expertise of the living liver donor transplant team broadens the Simmons Transplant Institute’s services and offers liver transplant patients hope for better outcomes and improved quality of life.

Other members of the Baylor multidisciplinary team for the living liver donor include:

  • Surgeon
  • Hepatologist
  • Physician Advocate
  • Living Donor Advocate
  • Living Donor Transplant Coordinator
  • Social Workers
  • Transplant Nurses

Baylor Health Center at Lubbock Opens!

Kidney transplant patients in Lubbock and the surrounding area have a new option when it comes to treatment and transplant for kidney failure. They can be evaluated and have their transplant kidney care provided in Lubbock by a transplant nephrologist at the Baylor Health Center at Lubbock.

Located at 3711 22 nd Street, Suite B in the heart of the hospital district, transplant nephrologist Bernard Fischbach, MD is on site every Thursday. The new facility provides local transplant nephrology consultations for kidney transplant candidates. In addition, kidney transplant recipients who receive their organ at Baylor All Saints Medical Center in Fort Worth or at Baylor University Medical Center in Dallas can receive their follow-up care at this new facility. In the future full on-site pre-transplant evaluations will also be available in Lubbock.

The Baylor Health Center in Lubbock was established to provide easier access for Lubbock area residents to the Annette C. and Harold C. Simmons Transplant Institute in Dallas and Fort Worth where approximately 200 kidney transplants are performed every year.

Kidney transplant options include:

  • Living Donor Kidney Transplants
  • Paired Donor Kidney Transplants
  • Kidney/Pancreas Transplants
  • Deceased Donor Transplants

For appointments in Lubbock call 806-722-0105

Survival Rates

Many of our transplant recipients are approaching their 25-year survival milestones and are leading rich and productive lives.

  • Baylor Dallas' 3-year liver transplant patient survival rate is an impressive 83.13% which exceeds the expected rate of 78.99%.
  • Baylor Dallas' 3-year kidney transplant patient survival rate is 94.58% which is above the expected rate of 92.64%.

We attribute this success to Baylor investigators’ participation in developing today’s more effective anti-rejection drugs that are far less toxic than those used in the past.

 

 



 

Research & Clinical Trials

Baylor Research Institute